Literature DB >> 9368783

Paraneoplastic syndromes.

J B Posner1, J Dalmau.   

Abstract

Paraneoplastic syndromes (i.e. organ/tissue disorders associated with cancer) affecting the nervous system are thought to be the result of an autoimmune response triggered by specific cancer antigens. Several of these antigens have recently been identified and include the Hu, Yo and Ri proteins, with the Hu antigens being the best studied. Immunization of animals with HuD has been shown to retard the growth of HuD-positive neuroblastomas. In addition, the presence of anti-HuD antibody in humans with small-cell lung cancer predicts the slow growth of the tumor. The associated neurological disorders, however, limit the use of these and other antigens with similar characteristics in cancer vaccines.

Entities:  

Mesh:

Year:  1997        PMID: 9368783     DOI: 10.1016/s0952-7915(97)80055-6

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  16 in total

1.  Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.

Authors:  A O Güre; E Stockert; M J Scanlan; R S Keresztes; D Jäger; N K Altorki; L J Old; Y T Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 2.  Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors:  E M Tan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

Review 3.  Cytoplasmic RNA-binding proteins and the control of complex brain function.

Authors:  Jennifer C Darnell; Joel D Richter
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

4.  A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators.

Authors:  Hui Zhu; Robert A Hasman; Victoria A Barron; Guangbin Luo; Hua Lou
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

5.  Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

Authors:  M Hardy-Werbin; O Arpí; A Taus; P Rocha; D Joseph-Pietras; L Nolan; S Danson; R Griffiths; M Lopez-Botet; A Rovira; J Albanell; C H Ottensmeier; E Arriola
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

Review 6.  B lymphocytes and cancer: a love-hate relationship.

Authors:  Grace J Yuen; Ezana Demissie; Shiv Pillai
Journal:  Trends Cancer       Date:  2016-12

7.  Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome.

Authors:  S Berghs; F Ferracci; E Maksimova; S Gleason; N Leszczynski; M Butler; P De Camilli; M Solimena
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

8.  Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.

Authors:  Claudio Gambini; Massimo Conte; Gabriella Bernini; Paola Angelini; Andrea Pession; Paolo Paolucci; Alberto Donfrancesco; Edvige Veneselli; Katia Mazzocco; Gian Paolo Tonini; Lizzia Raffaghello; Carlo Dominici; Adriana Morando; Francesca Negri; Anna Favre; Bruno De Bernardi; Vito Pistoia
Journal:  Virchows Arch       Date:  2003-04-23       Impact factor: 4.064

9.  Immune response in lung cancer mouse model mimics human anti-Hu reactivity.

Authors:  Meleeneh Kazarian; Joaquim Calbo; Natalie Proost; Catherine L Carpenter; Anton Berns; Ite A Laird-Offringa
Journal:  J Neuroimmunol       Date:  2009-09-17       Impact factor: 3.478

Review 10.  Autoantibodies to tumor-associated antigens: reporters from the immune system.

Authors:  Eng M Tan; Jianying Zhang
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.